Oncology & Cancer

Canceling cancer with T cells

What if we could engineer our immune system to make the human body better at fighting cancer? Professor Roy Mariuzza is part of a major research effort aimed at doing just that. An expert in the structural biology of immune ...

Oncology & Cancer

Receptor structure reveals new targets for cancer treatment

A molecule known as anaplastic lymphoma kinase (ALK) is a driver of several cancers, including pediatric neuroblastoma, B-cell lymphomas, and myofibroblast tumors. But for years much about this molecule—its role in the ...

Medical research

Scientists accelerate path to drugs for COVID-19

Scientists at The University of Manchester have developed a more efficient method to produce medicines that are in development for the treatment of COVID-19, cancer and other diseases that affect many of the world's population.

Medical research

Viral 'molecular scissor' is next COVID-19 drug target

American and Polish scientists, reporting Oct. 16 in the journal Science Advances, laid out a novel rationale for COVID-19 drug design—blocking a molecular "scissor" that the virus uses for virus production and to disable ...

page 1 from 4